Immune response to an indigenously developed hepatitis-B (Shanvac-B) vaccine in a tribal community of India

By Murhekar M.V.   Murhekar K.M.   Arankalle V.A.   Sehgal S.C.  

Vaccine, Vol. 20, Iss. 29, 2002-10 ,pp. : 3431-3435

Elsevier

Access to resources Recommend Favorite

Progress in DNA vaccine for prophylaxis and therapy of hepatitis B

By Thermet A.   Rollier C.   Zoulim F.   Trepo C.   Cova L.  

Vaccine, Vol. 21, Iss. 7, 2003-01 ,pp. : 659-662

Elsevier

Access to resources Recommend Favorite

Persistence of anti-HBs antibodies in health care personnel vaccinated with plasma-derived hepatitis B vaccine and response to recombinant DNA HB booster vaccine

By Trivello R.   Chiaramonte M.   Ngatchu T.   Baldo V.   Majori S.   Moschen M.E.   Simoncello I.   Renzulli G.   Naccarato R.  

Vaccine, Vol. 13, Iss. 2, 1995-02 ,pp. : 139-141

Elsevier

Access to resources Recommend Favorite

Persistence of immunologic memory for 13 years in recipients of a recombinant hepatitis B vaccine

By Watson B.   West D.J.   Chilkatowsky A.   Piercy S.   Ioli V.A.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3164-3168

Elsevier

Access to resources Recommend Favorite

Over a decade of experience with a yeast recombinant hepatitis B vaccine

By Assad S.   Francis A.  

Vaccine, Vol. 18, Iss. 1, 1999-08 ,pp. : 57-67

Elsevier

Access to resources Recommend Favorite